CN1927146A - Technical project of controlling and treating hypertension by periodically letting blood for definite quantity - Google Patents
Technical project of controlling and treating hypertension by periodically letting blood for definite quantity Download PDFInfo
- Publication number
- CN1927146A CN1927146A CN 200510096008 CN200510096008A CN1927146A CN 1927146 A CN1927146 A CN 1927146A CN 200510096008 CN200510096008 CN 200510096008 CN 200510096008 A CN200510096008 A CN 200510096008A CN 1927146 A CN1927146 A CN 1927146A
- Authority
- CN
- China
- Prior art keywords
- blood
- definite quantity
- scheme
- controlling
- technical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention relates to a method for treating high blood pressure quantitative periodically. Wherein, it is based on the theory that the female menses can prolong service life, to periodically and quantitatively discharge blood of the patient with high blood pressure, to use the metabolism recover function of body to treat and control high blood pressure. The invention can be used to attend old man and menopause females.
Description
The present invention relates to a kind of technical scheme of controlling and treating hypertension by periodically letting blood for definite quantity.The technical scheme of the regular letting blood for definite quantity control of particularly a kind of self-blood metabolism repair function that utilizes set patient treatment essential hypertension also provides new mode for the middle-aging male of needs health care and the long-life health care of menopausal womens simultaneously.
The present invention does not find the reference material of same background at present.Online enquiries have Tibetan medicine's venation therapy of blood-letting, also are " Blood-Letting Therapy ", do not have the class same sex with essence of the present invention.
The object of the present invention is to provide a kind of technical scheme of brand-new treatment essential hypertension; break the ill balance of patient's self blood circulation by the method for regularly quantitatively supervising blood-letting; reduce blood volume; the dilute blood composition; utilize human body to have the function of self-regeneration; activate and recovery blood of human body metabolic function; make the primary hypertension patient that to cure with present technology; particularly hemetaboly function is normal or can recover the primary hypertension patient of its hemetaboly function after ancillary drug and food help, and is effectively controlled and treats.
Purpose of the present invention can reach by following measure: through being diagnosed as the patient of essential hypertension, check the function of its blood metabolic system, determine patient's the metabolism cycle, calculate patient's blood volume, with reference to " Blood Donation Law of the People's Republic of China " or other medical literature data, determine set patient's blood-letting cycle and blood-letting quantity by the professional.After emitting quantitative blood, make fresh blood by patient's self haematogenous mechanism and the metabolic system of self, follow-up investigations, periodic analysis blood samples of patients composition and inspection blood metabolic function and blood volume, ancillary drug, food, water and moderate exercise etc. in case of necessity.
The regular letting blood for definite quantity control treatment essential hypertension technical scheme that the present invention relates to, included correlative factor has: set primary hypertension patient; Periodic monitoring blood samples of patients composition and blood pressure; Set patient's blood metabolic system; Regular letting blood for definite quantity; Ancillary drug conditioning etc.
Existing mature technology thinks that influencing hypertensive factor has three: 1, increase and decrease blood volume; 2, the contraction of blood vessel or expansion; 3, cardiac contractile force.Under the normal condition, these three factors are scope normally all, and for the hyperpietic, the technical specification of one of them factor exceeds standard.In other words, change wherein any one index, all can change human blood-pressure.Wherein, increase and decrease blood volume surface is a physical method, to promoting the blood metabolism, changes haemoconcentration and blood flow rate in fact, and crucial effects is all arranged.
According to the data record, only the present hyperpietic of China reaches 1.6 hundred million more than, and wherein 90% is the essential hypertension that present technology is difficult to cure, and 1.44 hundred million crowd is promptly arranged.With prior art, 1.44 hundred million primary hypertension patients of China can only carry out expectant treatment at present, and general medicine blood pressure lowering can produce very big huge psychological burden and physiological load to the patient.
The regular letting blood for definite quantity control treatment essential hypertension technical scheme that the present invention relates to, the direct method of enforcement is exactly to the regular letting blood for definite quantity of set patient, directly changes blood volume in patient's body.From physical factor, blood volume is few, can instant reduce patient's blood pressure, and effect is obvious, even after keeping the skin wet, also can reduce blood " viscosity ", dilute blood concentration, when reducing blood flow to heart, the mobile comparative resistance of blood vessel.From physiologic factor, set patient's body inner blood emit a certain amount of after, can break its circulation of original body inner blood and metabolic state, intravital self-regeneration function can be impelled and rebulids new metabolic mechanism, produce compensatory effect, the patient is taken comfort.
Have data to show, general women's average life is longer than the male.Think that regulate women's menstrual period is the magic weapon of safeguarding its body intracellular metabolic system.Comparatively speaking, the male lacks the natural metabolic mechanism of control agent inner blood on physiological structure.By human intervention, the method for regular letting blood for definite quantity, to the essential hypertension that can't cure at present, particularly the between twenty and fifty patient of male controls treatment, should have important breakthrough.In addition, the blood metabolic function affects the function of each big organ pipe such as people body-centered, brain, liver,spleen,kidney, and theory says, changes blood volume and metabolism composition, and the metabolic function of system in the body is had valuable help.
In addition, use the present invention, can provide brand-new health care mode by menopausal women coming for climacteric or that arrived in theory,, skin care, slow down aging are had effect because the blood metabolic system is directly connected to the physical function metabolism.
Of the present invention open, meaning is: novelty, uniqueness, feasibility are strong, have opened up a kind of method of new control treatment essential hypertension, provide new mode for male's long-life health care simultaneously.Utilize existing mature technique to ensure, the rule that utilization has now found that is done foundation, run counter in the past and be accustomed to,, be used for the hyperpietic scheme of control treatment the thought of " gynecologic menstrual metabolism reparation " by the hyperpietic medical treatment of medicine control expectant treatment.The people is a metabolic balance of breaking set patient itself, activates and utilize human body self blood metabolic function, reaches control and treats the disease that present technology can't be cured.
Of the present invention open, meaning also is: set primary hypertension patient, if himself blood metabolic function can normally activate, and through regular letting blood for definite quantity, by monitoring, and ancillary drug, but the purpose of achieve effective control patient blood pressure.Behind the human activin blood metabolic function, make each big organ pipe that comprises the blood manufacturing system of health, can both break outmoded operating mechanism, find new balance,, reach the purpose of control disease, building body, life lengthening from material guarantee mechanism aspect.
Of the present invention open, meaning also is: for being diagnosed as the patient of essential hypertension, provide brand-new medical skill scheme.Just the achievement of medical research at present shows that mental pressure is the key factor that influences patient's hypertension.The mode that the present invention understands from the conventional meaning easily, directly reduce blood volume, the patient has directly received the effect of blood minimizing, blood pressure drops, strengthen to tackle the confidence of disease, and the essential hypertension of walking to have the medical skill identification must be taken medicine conservative control throughout one's life but the psychological mistaken ideas that can't cure.
Of the present invention open, meaning also is: utilize the legal assurance of " Blood Donation Law of the People's Republic of China ", with reference to existing rule, provide one can effectively control and treat hyperpietic approach in theory.
Of the present invention open, meaning also is: under the condition of medical professionalism personage Additional Specialty instrument, blood metabolic function to the needs health care needs activated crowd to implement, wake and improve system's metabolic function of health up, middle-aging male and the foster guarantor's face long-life health care that holds of menopausal women in particular for the needs health care provide new mode, make male health-care that revolutionary leap take place on mode.
Claims (5)
1, a kind of technical scheme of controlling and treating hypertension by periodically letting blood for definite quantity is characterized in that: the technical scheme of utilizing set patient's the regular letting blood for definite quantity control of self-blood metabolism repair function treatment essential hypertension.
2, press the technical scheme of the controlling and treating hypertension by periodically letting blood for definite quantity of claim 1 regulation, it is characterized in that: set primary hypertension patient, at the blood metabolic function basic normal and can activated condition under, utilize the regular letting blood for definite quantity of patient self repair function, reach the purpose of control treatment essential hypertension.
3, press the technical scheme of the controlling and treating hypertension by periodically letting blood for definite quantity of claim 1 regulation, it is characterized in that: in the control treatment medical scheme, the technology implementation process is regular, and quantitative blood is discharged through human vein.
4, press the technical scheme of the controlling and treating hypertension by periodically letting blood for definite quantity of claim 1 regulation, it is characterized in that: letting blood for definite quantity measure is regularly operated by the medical professionalism personage, and have that the professional medical instrument monitoring is auxiliary to carry out, implementing process of the present invention is commercial medical act.
5, press the technical scheme of the controlling and treating hypertension by periodically letting blood for definite quantity of claim 1 regulation, it is characterized in that: under the condition of medical professionalism personage Additional Specialty instrument, the blood of human body metabolic function is needed to activate, implement commercial medical services in particular for the middle-aging male and the foster guarantor's face long-life health care that holds of menopausal women of needs health care.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510096008 CN1927146A (en) | 2005-09-09 | 2005-09-09 | Technical project of controlling and treating hypertension by periodically letting blood for definite quantity |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510096008 CN1927146A (en) | 2005-09-09 | 2005-09-09 | Technical project of controlling and treating hypertension by periodically letting blood for definite quantity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1927146A true CN1927146A (en) | 2007-03-14 |
Family
ID=37857386
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200510096008 Pending CN1927146A (en) | 2005-09-09 | 2005-09-09 | Technical project of controlling and treating hypertension by periodically letting blood for definite quantity |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1927146A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102488536A (en) * | 2011-11-11 | 2012-06-13 | 绍兴文理学院 | Human body blood pressure limiter |
| CN113455576A (en) * | 2021-07-29 | 2021-10-01 | 河南名医堂中医技术研究院有限公司 | Method for regulating and treating primary hypertension by syndrome differentiation of two drugs and one drug in traditional Chinese medicine |
-
2005
- 2005-09-09 CN CN 200510096008 patent/CN1927146A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102488536A (en) * | 2011-11-11 | 2012-06-13 | 绍兴文理学院 | Human body blood pressure limiter |
| CN102488536B (en) * | 2011-11-11 | 2014-07-02 | 绍兴文理学院 | Human body blood pressure limiter |
| CN113455576A (en) * | 2021-07-29 | 2021-10-01 | 河南名医堂中医技术研究院有限公司 | Method for regulating and treating primary hypertension by syndrome differentiation of two drugs and one drug in traditional Chinese medicine |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106943134A (en) | A kind of wearable blood pressure regulation device | |
| Simpson et al. | iv: Compressed Air as Therapeutic Agent in the Treatment of | |
| CN1927146A (en) | Technical project of controlling and treating hypertension by periodically letting blood for definite quantity | |
| Huang et al. | Management of elderly burn patients | |
| NOBIN et al. | Reserpine treatment of Raynaud's disease | |
| CN107823622A (en) | A kind of pharmaceutical composition for treating cold urticaria and its production and use | |
| CN112002395A (en) | Heart protection recommendation method based on perioperative period of great cardiac vascular surgery | |
| Lotfollahi et al. | Anti-inflammatory properties of high-density lipoproteins in diabetic wound healing. | |
| Maguire et al. | The impact of venous leg ulcers on wellbeing and quality of life. | |
| McMullin | Use of a wireless sub-bandage pressure monitor to improve application of compression bandages. | |
| CN215995046U (en) | Visual large-caliber blood vessel access fixing application | |
| Simek et al. | Accidental deep hypothermia with cardiac arrest. Prompt complete recovery after rewarming by extracorporeal circulation. Case report. | |
| CN213964704U (en) | Oxygen supply tank control circuit for respiratory medicine nursing | |
| McCormick et al. | An Appropriate Population for Acute Inpatient Rehabilitation? A Case Series of Three Patients With Advanced Heart Failure on Continuous Inotropic Support | |
| CN209137133U (en) | A kind of multi-functional oxygen therapy bed | |
| Yu et al. | Correlation of sarcopenia and metabolic risk factors | |
| Ciobanu et al. | Novel ambulatory blood pressure monitoring derived parameters and cardiac remodeling in arterial hypertension | |
| Luo et al. | The Effectiveness of Bax/Bcl-2 Gene Expression Ratio, Cardiac Function and Pulmonary Hemodynamics Indexes caused by Cardiopulmonary Rehabilitation Nursing | |
| Parsons | 4 Improvements in orthostatic tolerance with physical training are augmented with heat acclimation and associated plasma volume expansion; a randomised controlled trial | |
| CN109954095A (en) | A kind of application method of Chinese medicine composition that treating hypertension | |
| Dafalla et al. | Effects of Hemodialysis on Serum Copper and Zinc Levels in Sudanese Patients with Chronic Kidney Disease | |
| Singer et al. | 207: Epidemiology of Burns in the ED, 1996-2004 | |
| Garcia-Donaire et al. | EXPERIENCE WITH SINGLE AND MULTIELECTRODE CATHETER IN RENAL DENERVATION | |
| CN102512280B (en) | Manual pressure regulating device of medical sub-hypothermia ice blanket | |
| CN107823625A (en) | A kind of traditional Chinese powder medicine for treating coronary heart disease myocardial infarction angina pectoris arrhythmia cordis heart failure |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20070314 |